|
|
When Betty Malowney was diagnosed with breast cancer eight years ago, she underwent a modified radical mastectomy that required six weeks of recovery from surgery. Last year, a new cancer appeared in her other breast. But this time, says Betty, the difference in her treatment was like “night and day.” Betty had a far less invasive treatment at Overlake Hospital in Bellevue, Washington, that involved a lumpectomy and five days of outpatient radiation therapy with high-dose-rate (HDR) brachytherapy. The treatment was made possible by a GammaMed® afterloader from Varian Medical Systems and a MammoSite™ device from Proxima Therapeutics. Just one week after treatment, the 57-year-old high school teacher was swimming and boating with friends. “The ability for people to go on with their lives in a matter of days has been transforming,” says James Pelton, MD, medical director at Overlake Radiation Oncology. BRINGING THE TREATMENT CLOSER TO THE TUMOR
“HDR brachytherapy systems use very small catheters, meaning they can be placed virtually anywhere in the body,” says Peter Hoskin, MD, consultant clinical oncologist and professor, Mount Vernon Hospital in Northwood, England. “It allows us to give a very high dose of radiation to the target, while the surrounding area receives a very low dose.” “We have a fully integrated suite of brachytherapy products in one treatment room,” says Rose Guerrero, oncology service line director at Overlake Hospital. Clinicians use Varian’s Acuity™ imaging system to see the patient’s anatomy and guide the placement of catheters and radiation sources. |
Page 1 | 2
James Pelton, MD, Overlake Hospital, with cancer survivor Betty Malowney.
|
||||||||||||||||||||||||||